Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Bayer acquires Noria and PSMA Therapeutics to expand portfolio in prostate cancer

Friday, June 04, 2021

Bayer today announced that it has entered into an agreement to acquire Noria Therapeutics Inc Noria and PSMA Therapeutics Inc Through this acquisition Bayer will obtain exclusive rights to a differentiated alpha radionuclide therapy based on actinium...

BioCryst Launches ORLADEYO™ (berotralstat) in Germany

Friday, June 04, 2021

BioCryst Pharmaceuticals Inc today announced that oral oncedaily ORLADEYO berotralstat is now available for patients with a prescription in Germany ORLADEYO was approved by the European Medicines Agency EMA on April for the prevention of recurrent...

GenScript Biotech and Ligand Pharmaceuticals Enter into Global OmniAb® Licensing Agreement

Thursday, June 03, 2021

GenScript Biotech Corporation along with its subsidiary GenScript ProBio and Ligand Pharmaceuticals Incorporated announced today that they have entered into a strategic licensing agreement for Ligands OmniAb Platform a multispecies antibody discovery...

Primordial Genetics Grants Arcturus Therapeutics Exclusive License of an RNA Polymerase for Human and Animal Therapeutics

Thursday, June 03, 2021

Primordial Genetics a synthetic biology company developing enzymatic production systems for nucleic acids today announced granting Arcturus Therapeutics Holdings Inc a clinicalstage messenger RNA mRNA medicines company an exclusive license of an enzy...

Moderna Announces Agreement with Thermo Fisher Scientific for Fill/Finish Manufacturing of Moderna’s COVID-19 Vaccine

Wednesday, June 02, 2021

Moderna Inc a biotechnology company pioneering messenger RNA mRNA therapeutics and vaccines today announced that it has entered into an agreement with Thermo Fisher Scientific NYSE TMO for fillfinish sterile manufacturing services and supply packagin...

POINT Biopharma Receives U.S. Nuclear Regulatory Commission Materials License for Indiana Facility

Wednesday, June 02, 2021

POINT Biopharma Inc a radiopharmaceutical company dedicated to bringing the many benefits of precision radioligand therapy to cancer patients announced today that the US Nuclear Regulatory Commission NRC has issued a Materials License for its new pro...

Nexturn Bio Inc. acquired a 50% stake in RosVivo Therapeutics, Inc.

Tuesday, June 01, 2021

Nexturn Bio Inc a subsidiary of Nexturn Bioscience Co Ltd announced on May th that it had acquired a stake in RosVivo Therapeutics Inc Rosvivo an American new drug developer for about million US dollars As a result Nexturn Bio Inc strengthens its c...

Samsung Biologics to add mRNA vaccine drug substance manufacturing suite to expand portfolio of services

Tuesday, June 01, 2021

Samsung Biologics a leading global CDMO providing endtoend contract development and manufacturing services today announced its plans to add mRNA vaccine drug substance DS manufacturing capability to the current facility in Songdo ready for cGMP opera...

Seelos Therapeutics Receives European Orphan Drug Designation for SLS-005 (Trehalose) in Amyotrophic LateralSclerosis (ALS)

Friday, May 28, 2021

Seelos Therapeutics Inc a clinicalstage biopharmaceutical company focused on thedevelopment of therapies for central nervous system disorders and rare diseases today announced it has received European OrphanDrug Designation for SLS in amyotrophic lat...

Antengene Announces First Patient Dosed in Phase I/II Trial of Eltanexor for the Treatment of Myelodysplastic Syndrome

Friday, May 28, 2021

Antengene Corporation Limited a leading innovative biopharmaceutical company dedicated to discovering developing and commercializing global firstinclass andor bestinclass therapeutics in hematology and oncology today announced the dosing of the first...